Here are analysts' views on 11 stocks. Citi says Aurobindo Pharma remains India's top pharma pick as Teva business passes by and key overhang is lifted. It expects focus to shift back to company's robust fundamentals.
Disclaimer: Past performance is no guarantee of similar future returns. The investments discussed or recommended in this platform may not be suitable for all investors. Investors should use this advisory service as just one additional input when formulating their investment opinions.
Version 1.0.0